Dementia in other diseases classified elsewhere, unspecified severity, with agitation
ICD-10 F02.811 is a billable code used to indicate a diagnosis of dementia in other diseases classified elsewhere, unspecified severity, with agitation.
F02.811 refers to dementia that occurs as a result of other diseases not specifically classified under dementia categories, such as Parkinson's disease, Huntington's disease, or multiple sclerosis. This code is used when the severity of dementia is unspecified but is accompanied by agitation, which can manifest as restlessness, irritability, or aggressive behavior. Agitation in dementia patients can complicate care and management, often requiring tailored interventions. Cognitive assessments, such as the Mini-Mental State Examination (MMSE) or the Montreal Cognitive Assessment (MoCA), are crucial for evaluating the extent of cognitive impairment. Behavioral symptoms associated with this code can significantly impact the quality of life for both patients and caregivers, necessitating comprehensive support strategies. Caregiver education and support are vital, as caregivers often face challenges in managing agitation and other behavioral symptoms, which can lead to caregiver burnout if not addressed adequately.
Detailed neurological assessments, cognitive testing results, and behavioral observations.
Patients presenting with cognitive decline and agitation due to neurodegenerative diseases.
Ensure comprehensive documentation of both cognitive and behavioral symptoms to support the use of F02.811.
Psychiatric evaluations, treatment plans addressing agitation, and caregiver support strategies.
Management of agitation in dementia patients with underlying psychiatric conditions.
Document the impact of agitation on the patient's daily functioning and caregiver stress.
Used to assess cognitive function in patients with dementia and agitation.
Results of cognitive assessments and behavioral observations.
Neurologists and psychiatrists should ensure thorough documentation of test results.
Documenting agitation is crucial as it impacts treatment decisions, caregiver support needs, and overall patient management strategies.
